Clinical opinion spotlight: A sustainable model for improving access to mobile mammography for underserved populations

Minority women face disproportionately higher risks of breast cancer diagnosis and mortality under 50. Mobile mammography vans enhance screening accessibility but face challenges like long-term funding and operational viability. This study assesses existing mobile mammography van programs and propos...

Full description

Saved in:
Bibliographic Details
Published in:Current problems in diagnostic radiology
Main Authors: Badve, Rohan, Reddy, Sidhvi, Zalasin, Stefanie, Zamora, Kathryn, Yalniz, Ceren, Woodard, Stefanie
Format: Journal Article
Language:English
Published: United States Elsevier Inc 09-10-2024
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Minority women face disproportionately higher risks of breast cancer diagnosis and mortality under 50. Mobile mammography vans enhance screening accessibility but face challenges like long-term funding and operational viability. This study assesses existing mobile mammography van programs and proposes a sustainable model through literature review and qualitative interviews at a tertiary care academic medical center. The proposed model emphasizes partnerships, sponsorships and long-term funding for ensuring workforce sustainability. Organizational structure, budget allocation, patient workflow and follow-up protocols are aimed at transitioning towards serving primarily uninsured patients while maintaining financial stability. This sustainable approach hopes to enhance screening rates and timely care for underserved women, suggesting scalability and potential to reduce late-stage diagnoses and mortality. Continued implementation and evaluation are essential for validating feasibility and effectiveness, ensuring long-term improvement in screening rates and program longevity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0363-0188
1535-6302
1535-6302
DOI:10.1067/j.cpradiol.2024.10.004